{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T19:05:00Z","timestamp":1791313500812,"version":"4.3.1"},"reference-count":65,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"am","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004328","name":"Genentech","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004328","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"NEI","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["canadianjournalofophthalmology.ca","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Ophthalmology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.jcjo.2025.04.009","type":"journal-article","created":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T00:02:13Z","timestamp":1749168133000},"page":"e858-e868","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Short-term effects of tetracycline use in patients with diabetic retinopathy"],"prefix":"10.1016","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9465-8994","authenticated-orcid":false,"given":"Ahmed M.","family":"Alshaikhsalama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amer F.","family":"Alsoudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8980-2242","authenticated-orcid":false,"given":"Karen M.","family":"Wai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Euna","family":"Koo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prithvi","family":"Mruthyunjaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3135-1922","authenticated-orcid":false,"given":"Christina Y.","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ehsan","family":"Rahimy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcjo.2025.04.009_bib0001","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1001\/jamaophthalmol.2023.2289","article-title":"Prevalence of diabetic retinopathy in the US in 2021","volume":"141","author":"Lundeen","year":"2023","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.jcjo.2025.04.009_bib0002","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s40662-015-0026-2","article-title":"Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss","volume":"2","author":"Lee","year":"2015","journal-title":"Eye Vis (Lond)"},{"key":"10.1016\/j.jcjo.2025.04.009_bib0003","article-title":"Efficacy and safety of various treatments for proliferative diabetic retinopathy: a systematic review and network meta-analysis","volume":"12","author":"Zhang","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jcjo.2025.04.009_bib0004","doi-asserted-by":"crossref","first-page":"649","DOI":"10.2174\/1573399815666190916114040","article-title":"Water soluble vitamins and their role in diabetes and its complications","volume":"16","author":"Deshmukh","year":"2020","journal-title":"Curr Diabetes Rev"},{"key":"10.1016\/j.jcjo.2025.04.009_bib0005","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1159\/000499020","article-title":"The protective roles of folic acid in preventing diabetic retinopathy are potentially associated with suppressions on angiogenesis, inflammation, and oxidative stress","volume":"62","author":"Lei","year":"2019","journal-title":"Ophthalmic Res"},{"key":"10.1016\/j.jcjo.2025.04.009_bib0006","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/j.bbrc.2018.07.041","article-title":"Alpha-lipoic acid reduces retinal cell death in diabetic mice","volume":"503","author":"Kim","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jcjo.2025.04.009_bib0007","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1001\/archopht.126.9.1266","article-title":"Inhibition of retinopathy and retinal metabolic abnormalities in diabetic rats with AREDS-based micronutrients","volume":"126","author":"Kowluru","year":"2008","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jcjo.2025.04.009_bib0008","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s40662-020-00199-y","article-title":"Nutritional and medical food therapies for diabetic retinopathy","volume":"7","author":"Shi","year":"2020","journal-title":"Eye Vis (Lond)"},{"key":"10.1016\/j.jcjo.2025.04.009_bib0009","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/8193523","article-title":"Vitamin D3 protects against diabetic retinopathy by inhibiting high-glucose-induced activation of the ROS\/TXNIP\/NLRP3 inflammasome pathway","volume":"2018","author":"Lu","year":"2018","journal-title":"J Diabetes Res"},{"key":"10.1016\/j.jcjo.2025.04.009_bib0010","doi-asserted-by":"crossref","first-page":"3727","DOI":"10.1007\/s11033-011-1148-9","article-title":"Effect of antioxidant N-acetylcysteine on diabetic retinopathy and expression of VEGF and ICAM-1 from retinal blood vessels of diabetic rats","volume":"39","author":"Zhu","year":"2012","journal-title":"Mol Biol Rep"},{"key":"10.1016\/j.jcjo.2025.04.009_bib0011","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.ophtha.2023.12.026","article-title":"Faricimab treat-and-extend for diabetic macular edema: two-year results from the randomized Phase 3 YOSEMITE and RHINE Trials","volume":"131","author":"Wong","year":"2024","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jcjo.2025.04.009_bib0012","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s12933-016-0434-1","article-title":"Adequate vitamin D status is associated with the reduced odds of prevalent diabetic retinopathy in African Americans and Caucasians","volume":"15","author":"Millen","year":"2016","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.jcjo.2025.04.009_bib0013","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1136\/bjophthalmol-2014-306534","article-title":"The diabetes visual function supplement study (DiVFuSS)","volume":"100","author":"Chous","year":"2016","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jcjo.2025.04.009_bib0014","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1001\/jamaophthalmol.2018.6399","article-title":"Association of statin therapy with prevention of vision-threatening diabetic retinopathy","volume":"137","author":"Kang","year":"2019","journal-title":"JAMA Ophthalmology"},{"key":"10.1016\/j.jcjo.2025.04.009_bib0015","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/3096470","article-title":"Adjuvant therapies in diabetic retinopathy as an early approach to delay its progression: the importance of oxidative stress and inflammation","volume":"2020","author":"Robles-Rivera","year":"2020","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.jcjo.2025.04.009_bib0016","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/s41598-023-49937-x","article-title":"The relationship between blood vitamin A levels and diabetic retinopathy: a population-based study","volume":"14","author":"Choi","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.jcjo.2025.04.009_bib0017","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.2337\/diacare.22.8.1245","article-title":"High-dose vitamin E supplementation normalizes retinal blood flow and creatinine clearance in patients with type 1 diabetes","volume":"22","author":"Bursell","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcjo.2025.04.009_bib0018","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.2147\/OPTH.S46718","article-title":"Intervention with vitamins in patients with nonproliferative diabetic retinopathy: a pilot study","volume":"7","author":"Smolek","year":"2013","journal-title":"Clin Ophthalmol"},{"issue":"4 Suppl","key":"10.1016\/j.jcjo.2025.04.009_bib0019","first-page":"6","article-title":"The anti-inflammatory effects of tetracyclines","volume":"75","author":"Weinberg","year":"2005","journal-title":"Cutis"},{"key":"10.1016\/j.jcjo.2025.04.009_bib0020","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s12640-015-9592-2","article-title":"Doxycycline suppresses microglial activation by inhibiting the p38 MAPK and NF-\u03baB Signaling Pathways","volume":"29","author":"Santa-Cec\u00edlia","year":"2016","journal-title":"Neurotox Res"},{"key":"10.1016\/j.jcjo.2025.04.009_bib0021","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.2337\/diabetes.54.5.1559","article-title":"Minocycline reduces proinflammatory cytokine expression, microglial activation, and caspase-3 activation in a rodent model of diabetic retinopathy","volume":"54","author":"Krady","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.jcjo.2025.04.009_bib0022","doi-asserted-by":"crossref","first-page":"4887","DOI":"10.3892\/mmr.2015.4064","article-title":"Minocycline inhibits PARP\u20111 expression and decreases apoptosis in diabetic retinopathy","volume":"12","author":"Wu","year":"2015","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.jcjo.2025.04.009_bib0023","doi-asserted-by":"crossref","first-page":"3865","DOI":"10.1167\/iovs.11-9413","article-title":"Oral minocycline for the treatment of diabetic macular edema (DME): results of a phase I\/II clinical study","volume":"53","author":"Cukras","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jcjo.2025.04.009_bib0024","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1001\/jamaophthalmol.2014.93","article-title":"Effect of doxycycline vs placebo on retinal function and diabetic retinopathy progression in patients with severe nonproliferative or non\u2013high-risk proliferative diabetic retinopathy: a randomized clinical trial","volume":"132","author":"Scott","year":"2014","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.jcjo.2025.04.009_bib0025","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1177\/147323001103900214","article-title":"Expression of aquaporin 4 and Kir4.1 in diabetic rat retina: treatment with minocycline","volume":"39","author":"Zhang","year":"2011","journal-title":"J Int Med Res"},{"key":"10.1016\/j.jcjo.2025.04.009_bib0026","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1007\/s00417-023-05986-6","article-title":"Oral minocycline for the treatment of retinitis pigmentosa-associated cystoid macular edema: results of a phase I\/II clinical trial","volume":"261","author":"Dave","year":"2023","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.jcjo.2025.04.009_bib0027","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1001\/jamaophthalmol.2024.0118","article-title":"Phase 2 trial evaluating minocycline for geographic atrophy in age-related macular degeneration: a nonrandomized controlled trial","volume":"142","author":"Keenan","year":"2024","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.jcjo.2025.04.009_bib0028","first-page":"23","article-title":"Oral doxycycline reduces the total number of intraocular bevacizumab injections needed to control neovascular age-related macular degeneration","volume":"6","author":"Mirshahi","year":"2017","journal-title":"Med Hypothesis Discov Innov Ophthalmol"},{"key":"10.1016\/j.jcjo.2025.04.009_bib0029","doi-asserted-by":"crossref","first-page":"e297","DOI":"10.1371\/journal.pmed.0040297","article-title":"Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration","volume":"4","author":"Vandenbroucke","year":"2007","journal-title":"PLOS Med"},{"key":"10.1016\/j.jcjo.2025.04.009_bib0030","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1001\/jama.1954.02940410017005","article-title":"Clinical and laboratory observations of a new antibiotic, tetracycline","volume":"154","author":"Finland","year":"1954","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.jcjo.2025.04.009_bib0031","doi-asserted-by":"crossref","first-page":"5415","DOI":"10.1038\/s41598-022-09394-4","article-title":"Doxycycline prevents blood\u2013brain barrier dysfunction and microvascular hyperpermeability after traumatic brain injury","volume":"12","author":"Robinson","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.jcjo.2025.04.009_bib0032","series-title":"Handbook of neurotoxicity","first-page":"1539","article-title":"Doxycycline therapeutic approach in Parkinson\u2019s disease and L-DOPA-induced dyskinesia","author":"Del-Bel","year":"2022"},{"key":"10.1016\/j.jcjo.2025.04.009_bib0033","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1128\/MMBR.65.2.232-260.2001","article-title":"Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance","volume":"65","author":"Chopra","year":"2001","journal-title":"Microbiol Mol Biol Rev"},{"key":"10.1016\/j.jcjo.2025.04.009_bib0034","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jaad.2005.10.004","article-title":"Tetracyclines: nonantibiotic properties and their clinical implications","volume":"54","author":"Sapadin","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jcjo.2025.04.009_bib0035","first-page":"e1","article-title":"Systemic antibiotic treatment for meibomian gland dysfunction-A systematic review and meta-analysis","volume":"102","author":"Ben Ephraim Noyman","year":"2024","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.jcjo.2025.04.009_bib0036","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","article-title":"The NLRP3 inflammasome: molecular activation and regulation to therapeutics","volume":"19","author":"Swanson","year":"2019","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jcjo.2025.04.009_bib0037","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1093\/cvr\/cvs111","article-title":"Mitochondria in vascular disease","volume":"95","author":"Yu","year":"2012","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jcjo.2025.04.009_bib0038","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1128\/AAC.01411-05","article-title":"Inhibition of mammalian mitochondrial protein synthesis by oxazolidinones","volume":"50","author":"McKee","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jcjo.2025.04.009_bib0039","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1167\/iovs.17-22816","article-title":"Enhanced expression of NLRP3 inflammasome-related inflammation in diabetic retinopathy","volume":"59","author":"Chen","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jcjo.2025.04.009_bib0040","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1172\/JCI2425","article-title":"Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin","volume":"102","author":"Barber","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jcjo.2025.04.009_bib0041","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.97.22.12222","article-title":"Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation","volume":"97","author":"Du","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jcjo.2025.04.009_bib0042","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1038\/s41598-018-21198-z","article-title":"The NLRP3 inflammasome may contribute to pathologic neovascularization in the advanced stages of diabetic retinopathy","volume":"8","author":"Chaurasia","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.jcjo.2025.04.009_bib0043","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/aos.13427","article-title":"NLRP3 inflammasome activation is associated with proliferative diabetic retinopathy","volume":"95","author":"Loukovaara","year":"2017","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.jcjo.2025.04.009_bib0044","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/ni.1935","article-title":"Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1\u03b2 in type 2 diabetes","volume":"11","author":"Masters","year":"2010","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jcjo.2025.04.009_bib0045","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1038\/ni.2022","article-title":"Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling","volume":"12","author":"Wen","year":"2011","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jcjo.2025.04.009_bib0046","doi-asserted-by":"crossref","first-page":"4737","DOI":"10.1038\/s41467-020-18528-z","article-title":"Repurposing anti-inflammasome NRTIs for improving insulin sensitivity and reducing type 2 diabetes development","volume":"11","author":"Ambati","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.jcjo.2025.04.009_bib0047","doi-asserted-by":"crossref","DOI":"10.1016\/j.mvr.2021.104265","article-title":"Down-expression of the NLRP3 inflammasome delays the progression of diabetic retinopathy","volume":"139","author":"Ge","year":"2022","journal-title":"Microvasc Res"},{"key":"10.1016\/j.jcjo.2025.04.009_bib0048","first-page":"31","article-title":"Diverse NF-\u03baB expression in epiretinal membranes after human diabetic retinopathy and proliferative vitreoretinopathy","volume":"10","author":"Harada","year":"2004","journal-title":"Mol Vis"},{"key":"10.1016\/j.jcjo.2025.04.009_bib0049","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s00125-003-1084-x","article-title":"NF-\u03baB in epiretinal membranes after human diabetic retinopathy","volume":"46","author":"Mitamura","year":"2003","journal-title":"Diabetologia"},{"key":"10.1016\/j.jcjo.2025.04.009_bib0050","article-title":"Comparison of vitreous and plasma levels of vascular endothelial growth factor, interleukin-6 and hepatocyte growth factor in diabetic and non-diabetic retinal detachment cases","volume":"42","author":"Kocak","year":"2010","journal-title":"Ann Ophthalmol (Skokie)"},{"key":"10.1016\/j.jcjo.2025.04.009_bib0051","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0070459","article-title":"Angiopoietin-2 is critical for cytokine-induced vascular leakage","volume":"8","author":"Benest","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jcjo.2025.04.009_bib0052","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1007\/s13300-022-01326-9","article-title":"The role of angiopoietins in neovascular diabetes-related retinal diseases","volume":"13","author":"Collazos-Alem\u00e1n","year":"2022","journal-title":"Diabetes Ther"},{"key":"10.1016\/j.jcjo.2025.04.009_bib0053","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0140-6736(22)00018-6","article-title":"Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials","volume":"399","author":"Wykoff","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.jcjo.2025.04.009_bib0054","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.2337\/db10-1160","article-title":"Retinal microglial activation and inflammation induced by amadori-glycated albumin in a rat model of diabetes","volume":"60","author":"Ibrahim","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.jcjo.2025.04.009_bib0055","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.564077","article-title":"Microglia and inflammatory responses in diabetic retinopathy","volume":"11","author":"Kinuthia","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.jcjo.2025.04.009_bib0056","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1001\/archderm.1976.01630350071017","article-title":"Safety of long-term tetracycline therapy for acne","volume":"112","author":"Sauer","year":"1976","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jcjo.2025.04.009_bib0057","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1111\/j.1610-0387.2006.06053.x","article-title":"Systemic antibiotic therapy of acne vulgaris","volume":"4","author":"Ochsendorf","year":"2006","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.jcjo.2025.04.009_bib0058","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1136\/bmj.326.7390.641","article-title":"Doxycycline induced intracranial hypertension","volume":"326","author":"Lochhead","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.jcjo.2025.04.009_bib0059","first-page":"1137","article-title":"Intracranial pressure returns to normal about a month after stopping tetracycline antibiotics","volume":"48","author":"Winn","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jcjo.2025.04.009_bib0060","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1001\/archderm.1965.01600120060016","article-title":"Complications of tetracycline therapy","volume":"91","author":"Clendenning","year":"1965","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jcjo.2025.04.009_bib0061","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.jpeds.2016.03.034","article-title":"Severe and persistent thyroid dysfunction associated with tetracycline-antibiotic treatment in youth","volume":"173","author":"Pollock","year":"2016","journal-title":"J Pediatr"},{"key":"10.1016\/j.jcjo.2025.04.009_bib0062","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1001\/jama.1964.03060290111037","article-title":"Hepatic reactions to tetracycline","volume":"188","author":"Dowling","year":"1964","journal-title":"JAMA"},{"key":"10.1016\/j.jcjo.2025.04.009_bib0063","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/IIO.0b013e3182aabf11","article-title":"Epidemiology and risk factors for idiopathic intracranial hypertension","volume":"54","author":"Chen","year":"2014","journal-title":"Int Ophthalmol Clin"},{"key":"10.1016\/j.jcjo.2025.04.009_bib0064","first-page":"3648","article-title":"Different effects of minocycline and doxycycline on retinal vascular permeability and neurodegeneration in ischemia-reperfusion","volume":"51","author":"Lin","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jcjo.2025.04.009_bib0065","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.2147\/OPTH.S275968","article-title":"Five-year patterns of diabetic retinopathy progression in US clinical practice","volume":"14","author":"Moshfeghi","year":"2020","journal-title":"Clin Ophthalmol"}],"container-title":["Canadian Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008418225001577?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008418225001577?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T22:39:29Z","timestamp":1764628769000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0008418225001577"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":65,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S0008418225001577"],"URL":"https:\/\/doi.org\/10.1016\/j.jcjo.2025.04.009","relation":{},"ISSN":["0008-4182"],"issn-type":[{"value":"0008-4182","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Short-term effects of tetracycline use in patients with diabetic retinopathy","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcjo.2025.04.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Canadian Ophthalmological Society. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}